BIOMAT Database Logo BIOMAT Database Logo

Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease. 2016

Julien Vionnet, and Anne-Catherine Saouli, and Manuel Pascual, and Fabien Stucker, and Laurent Arthur Decosterd, and Darius Moradpour, and Haithem Chtioui
Transplantation Center, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland; Service of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland. Electronic address: Julien.Vionnet@chuv.ch.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D002219 Carbamates Derivatives of carbamic acid, H2NC( Carbamate,Aminoformic Acids,Carbamic Acids,Acids, Aminoformic,Acids, Carbamic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069474 Sofosbuvir A uridine monophosphate analog inhibitor of HEPATITIS C VIRUS (HCV) polymerase NS5B that is used as an ANTIVIRAL AGENT in the treatment of CHRONIC HEPATITIS C. 2-((5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy)phenoxyphosphorylamino)propionic acid isopropyl ester,GS-7977,PSI 7977,PSI-7977,PSI7977,Sovaldi,7977, PSI,GS 7977,GS7977
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014633 Valine A branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway. L-Valine,L Valine
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Julien Vionnet, and Anne-Catherine Saouli, and Manuel Pascual, and Fabien Stucker, and Laurent Arthur Decosterd, and Darius Moradpour, and Haithem Chtioui
Reply to: "Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease".
November 2016, Journal of hepatology,
Julien Vionnet, and Anne-Catherine Saouli, and Manuel Pascual, and Fabien Stucker, and Laurent Arthur Decosterd, and Darius Moradpour, and Haithem Chtioui
Treatment of chronic hepatitis C viral infection with sofosbuvir and daclatasvir in kidney transplant recipients.
February 2019, Transplant infectious disease : an official journal of the Transplantation Society,
Julien Vionnet, and Anne-Catherine Saouli, and Manuel Pascual, and Fabien Stucker, and Laurent Arthur Decosterd, and Darius Moradpour, and Haithem Chtioui
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.
April 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Julien Vionnet, and Anne-Catherine Saouli, and Manuel Pascual, and Fabien Stucker, and Laurent Arthur Decosterd, and Darius Moradpour, and Haithem Chtioui
Successful Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Ledipasvir in Renal Transplant Recipients.
May 2017, Transplantation,
Julien Vionnet, and Anne-Catherine Saouli, and Manuel Pascual, and Fabien Stucker, and Laurent Arthur Decosterd, and Darius Moradpour, and Haithem Chtioui
Treatment of hepatitis C in a lung transplant recipient with sofosbuvir and daclatasvir.
June 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Julien Vionnet, and Anne-Catherine Saouli, and Manuel Pascual, and Fabien Stucker, and Laurent Arthur Decosterd, and Darius Moradpour, and Haithem Chtioui
Successful Treatment of Chronic Hepatitis C Virus Infection with Sofosbuvir and Ledipasvir in Renal Transplant Recipients: Erratum.
October 2018, Transplantation,
Julien Vionnet, and Anne-Catherine Saouli, and Manuel Pascual, and Fabien Stucker, and Laurent Arthur Decosterd, and Darius Moradpour, and Haithem Chtioui
Hepatitis C associated chronic liver disease in renal transplant recipients.
January 1995, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
Julien Vionnet, and Anne-Catherine Saouli, and Manuel Pascual, and Fabien Stucker, and Laurent Arthur Decosterd, and Darius Moradpour, and Haithem Chtioui
Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD ≥ 15).
February 2018, Alimentary pharmacology & therapeutics,
Julien Vionnet, and Anne-Catherine Saouli, and Manuel Pascual, and Fabien Stucker, and Laurent Arthur Decosterd, and Darius Moradpour, and Haithem Chtioui
Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients With Chronic Hepatitis C Infection.
July 2018, Journal of pediatric gastroenterology and nutrition,
Julien Vionnet, and Anne-Catherine Saouli, and Manuel Pascual, and Fabien Stucker, and Laurent Arthur Decosterd, and Darius Moradpour, and Haithem Chtioui
Full-dose sofosbuvir and daclatasvir for chronic hepatitis C infection in haemodialysis patients.
June 2016, The Netherlands journal of medicine,
Copied contents to your clipboard!